These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
377 related items for PubMed ID: 28867602
1. A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis. Schwebke JR, Morgan FG, Koltun W, Nyirjesy P. Am J Obstet Gynecol; 2017 Dec; 217(6):678.e1-678.e9. PubMed ID: 28867602 [Abstract] [Full Text] [Related]
3. A Phase 3, Multicenter, Prospective, Open-Label Study to Evaluate the Safety of a Single Dose of Secnidazole 2 g for the Treatment of Women and Postmenarchal Adolescent Girls with Bacterial Vaginosis. Chavoustie SE, Gersten JK, Samuel MJ, Schwebke JR. J Womens Health (Larchmt); 2018 Apr; 27(4):492-497. PubMed ID: 29323627 [Abstract] [Full Text] [Related]
4. Two phase 3, double-blind, placebo-controlled studies of the efficacy and safety of Astodrimer 1% Gel for the treatment of bacterial vaginosis. Chavoustie SE, Carter BA, Waldbaum AS, Donders GGG, Peters KH, Schwebke JR, Paull JRA, Price CF, Castellarnau A, McCloud P, Kinghorn GR. Eur J Obstet Gynecol Reprod Biol; 2020 Feb; 245():13-18. PubMed ID: 31812702 [Abstract] [Full Text] [Related]
6. A phase 2, double-blind, multicenter, randomized, placebo-controlled, dose‑ranging study of the efficacy and safety of Astodrimer Gel for the treatment of bacterial vaginosis. Waldbaum AS, Schwebke JR, Paull JRA, Price CF, Edmondson SR, Castellarnau A, McCloud P, Kinghorn GR. PLoS One; 2020 Feb; 15(5):e0232394. PubMed ID: 32365097 [Abstract] [Full Text] [Related]
7. Low-dose secnidazole in the treatment of bacterial vaginosis. Núñez JT, Gómez G. Int J Gynaecol Obstet; 2005 Mar; 88(3):281-5. PubMed ID: 15733882 [Abstract] [Full Text] [Related]
14. A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of Metronidazole Vaginal Gel 1.3% in the Treatment of Bacterial Vaginosis. Schwebke JR, Marrazzo J, Beelen AP, Sobel JD. Sex Transm Dis; 2015 Jul; 42(7):376-81. PubMed ID: 26222750 [Abstract] [Full Text] [Related]
18. Secnidazole. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic use in the management of protozoal infections and bacterial vaginosis. Gillis JC, Wiseman LR. Drugs; 1996 Apr; 51(4):621-38. PubMed ID: 8706597 [Abstract] [Full Text] [Related]